Results 141 to 150 of about 900,428 (163)
Some of the next articles are maybe not open access.
Pediatric Surgery International, 2020
To investigate the efficacy and safety of combined therapy with adrenergic beta-antagonist and lasers in infantile hemangiomas (IH). A search of Pubmed, Cochrane, Embase, Wanfang Date, CNKI (China National Knowledge Infrastructure) and CBM (China Biology Medicine) databases was conducted to identify studies that examined response to combined therapy ...
Xingfan Chen +8 more
openaire +2 more sources
To investigate the efficacy and safety of combined therapy with adrenergic beta-antagonist and lasers in infantile hemangiomas (IH). A search of Pubmed, Cochrane, Embase, Wanfang Date, CNKI (China National Knowledge Infrastructure) and CBM (China Biology Medicine) databases was conducted to identify studies that examined response to combined therapy ...
Xingfan Chen +8 more
openaire +2 more sources
Beta adrenergic antagonists and antianginal drugs
Beta adrenergic antagonists and antianginal drugs are used with the aim to ultimately decrease mortality and enable patients to lead an improved quality of life by avoidance of anginal episodes.
Stever, Lindsey M. +9 more
exaly +2 more sources
Klinicheskaia meditsina, 1999
59 patients with mild and moderate essential hypertension have received a course treatment with beta-adrenoblocker proxodolol. The latter was studied for a hypotensive action and cardiohemodynamic effects as regards baseline type of circulation and pacing regimen.
B G, Iskenderov +2 more
openaire +2 more sources
59 patients with mild and moderate essential hypertension have received a course treatment with beta-adrenoblocker proxodolol. The latter was studied for a hypotensive action and cardiohemodynamic effects as regards baseline type of circulation and pacing regimen.
B G, Iskenderov +2 more
openaire +2 more sources
European Journal of Biochemistry, 1979
When adipocyte membranes are successively exposed to (−)‐propranolol or (±)‐alprenolo1 at 25 or 4°C, repeatedly washed and then assayed for (−)‐[3H]dihydroalprenolol binding, the apparent number of β‐adrenergic binding sites is markedly decreased. Induction of this peculiar type of receptor desensitization does not require prolonged exposure of the ...
Y, Giudicelli, D, Lacasa, B, Agli
openaire +2 more sources
When adipocyte membranes are successively exposed to (−)‐propranolol or (±)‐alprenolo1 at 25 or 4°C, repeatedly washed and then assayed for (−)‐[3H]dihydroalprenolol binding, the apparent number of β‐adrenergic binding sites is markedly decreased. Induction of this peculiar type of receptor desensitization does not require prolonged exposure of the ...
Y, Giudicelli, D, Lacasa, B, Agli
openaire +2 more sources
Life Sciences, 1976
Abstract (−)Alprenolol, a compound reported to bind with a high degree of specificity and stereoselectivity to β-adrenergic receptors from rat cerebral cortex completely inhibited the accumulations of cyclic AMP elicited by maximally effective concentrations of norepinephrine and epinephrine at antagonist concentrations as low as 10 −5 M.
P, Skolnick, J W, Daly
openaire +2 more sources
Abstract (−)Alprenolol, a compound reported to bind with a high degree of specificity and stereoselectivity to β-adrenergic receptors from rat cerebral cortex completely inhibited the accumulations of cyclic AMP elicited by maximally effective concentrations of norepinephrine and epinephrine at antagonist concentrations as low as 10 −5 M.
P, Skolnick, J W, Daly
openaire +2 more sources
Effects of Beta-Adrenergic Antagonists in Patients With Chronic Kidney Disease
Journal of the American College of Cardiology, 2011Carmel Hawley, Alan Cass
exaly
Effects of four beta-adrenergic receptor antagonists on male rat sexual behavior
Pharmacology Biochemistry and Behavior, 1990Rick Richardson +2 more
exaly
Beta-Adrenergic Antagonists Attenuate Somatic and Aversive Signs of Opiate Withdrawal
Neuropsychopharmacology, 1993Gary Aston-Jones +2 more
exaly

